Matador Resources Company

Description

Matador Resources Company, an independent energy company, engages in the exploration, development, production, and acquisition of oil and natural gas resources in the United States. It operates through two segments, Exploration and Production; and Midstream. The company primarily holds interests in the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. It also operates the Eagle Ford shale play in South Texas; and the Haynesville shale and Cotton Valley plays in Northwest Louisiana. In addition, the company conducts midstream operations in support of its exploration, development, and production operations. Further, it provides natural gas processing and oil transportation services; and oil, natural gas, and produced water gathering services, as well as produced water disposal services to third parties. The company sells natural gas to unaffiliated independent marketing companies and unaffiliated midstream companies. The company was formerly known as Matador Holdco, Inc. and changed its name to Matador Resources Company in August 2011. Matador Resources Company was founded in 2003 and is headquartered in Dallas, Texas.

About

CEO
Mr. Joseph Wm. Foran
Employees
395
Instrument type
Common Stock
Sector
Energy
Industry
Oil & Gas E&P
MIC code
XNYS
Address
One Lincoln Centre, Dallas, TX 75240, United States
Phone
972 371 5200
Website
Chart Image
× Enlarged Chart
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format

Earnings

Date Estimate EPS Actual EPS Difference % Surprise
Oct 20, 2025
Jul 21, 2025
Apr 21, 2025
Feb 18, 2025 1.88

Earnings estimate

Next Quarter
(Mar 2025)
Next Year
(Dec 2025)
Number of analysts 14 17
Average estimate 2.08 8.47
Low estimate 1.48 6.96
High estimate 2.58 10.37
Last year EPS 1.71 7.42
[stock_revenue_estimate]

Growth estimates

Current qtr
-11.200%
Next qtr. (Mar 2025)
21.890%
Current year
9.540%
Next year (Dec 2025)
14.190%
Next 5 years (per annum)
Past 5 years (per annum)

Analyst Ratings

Date Firm Action Rating Price Target
Jan 17, 2025
Benchmark
Subash Chandra
Reiterates Buy Maintains $62
Jan 15, 2025
RBC Capital
Scott Hanold
Reiterates Outperform Maintains $70
Jan 13, 2025
Truist Securities
Neal Dingmann
Maintains Buy ▲ Raises $75 → $80
Jan 10, 2025
Morgan Stanley
Devin McDermott
Initiates Equal-Weight Announces $78
Jan 3, 2025
Wolfe Research
Doug Leggate
Upgrade Outperform Maintains $72
Dec 19, 2024
TD Cowen
Gabe Daoud
Maintains Buy ▲ Raises $74 → $75
Dec 17, 2024
Wells Fargo
Hanwen Chang
Maintains Overweight ▲ Raises $87 → $91
Dec 16, 2024
Mizuho
William Janela
Maintains Outperform ▼ Lowers $74 → $73
Dec 6, 2024
RBC Capital
Scott Hanold
Maintains Outperform Maintains $70
Dec 6, 2024
Stephens & Co.
Mike Scialla
Maintains Overweight ▲ Raises $78 → $80
Oct 30, 2024
JP Morgan
Zach Parham
Maintains Overweight ▼ Lowers $77 → $71
Oct 24, 2024
RBC Capital
Scott Hanold
Reiterates Outperform Maintains $70
Oct 23, 2024
Stephens & Co.
Mike Scialla
Reiterates Overweight Maintains $78
Oct 23, 2024
Benchmark
Subash Chandra
Reiterates Buy Maintains $62
Oct 21, 2024
Stephens & Co.
Mike Scialla
Maintains Overweight ▲ Raises $76 → $78
Oct 16, 2024
Keybanc
Tim Rezvan
Maintains Overweight ▼ Lowers $76 → $72
Oct 4, 2024
BMO Capital
Phillip Jungwirth
Maintains Outperform ▲ Raises $75 → $78
Oct 1, 2024
Wells Fargo
Hanwen Chang
Maintains Overweight ▼ Lowers $89 → $87
Sep 30, 2024
Truist Securities
Neal Dingmann
Maintains Buy ▼ Lowers $86 → $75
Sep 27, 2024
Stephens & Co.
Mike Scialla
Maintains Overweight ▲ Raises $74 → $76
Sep 27, 2024
RBC Capital
Scott Hanold
Reiterates Outperform Maintains $75
Sep 20, 2024
RBC Capital
Scott Hanold
Reiterates Outperform Maintains $75
Sep 16, 2024
Mizuho
William Janela
Maintains Outperform ▼ Lowers $85 → $74
Sep 12, 2024
JP Morgan
Zach Parham
Maintains Overweight ▼ Lowers $83 → $76
Jul 29, 2024
Wells Fargo
Hanwen Chang
Maintains Overweight ▲ Raises $88 → $89
Jul 25, 2024
RBC Capital
Scott Hanold
Reiterates Outperform Maintains $75
Jul 24, 2024
TD Cowen
Gabe Daoud
Maintains Buy ▲ Raises $85 → $87
Jul 24, 2024
Stephens & Co.
Mike Scialla
Maintains Overweight ▼ Lowers $83 → $81
Jul 24, 2024
Benchmark
Subash Chandra
Reiterates Buy Maintains $62
Jul 22, 2024
Truist Securities
Neal Dingmann
Maintains Buy ▼ Lowers $91 → $86

Income statement

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total reported revenue 2.82B 3.20B 1.86B 855.20M 1.03B
Cost of revenue 1.48B 1.18B 771.44M 634.36M 666.31M
Gross profit 1.33B 2.02B 1.09B 220.84M 361.60M
Operating expense
Research & development
Selling general and admin 110.37M 116.23M 96.40M 62.58M 80.05M
Other operating expenses 3.94M 2.42M 2.07M 1.95M 1.82M
Operating income 1.22B 1.90B 992.17M 156.32M 279.73M
Non operating interest income
Income
Expense 121.52M 67.16M 74.69M 76.69M 73.87M
Other income expense -2.25M -145.11M -202.14M -678.78M -47.34M
Pretax income 1.10B 1.69B 715.35M -599.16M 158.51M
Tax provision 186.03M 399.36M 74.71M -45.60M 35.53M
Net income 910.36M 1.29B 640.64M -553.56M 122.98M
Basic EPS 7.10 10.28 5.00 -5.11 0.75
Diluted EPS 7.05 10.11 4.91 -5.11 0.75
Basic average shares 119.14M 118.12M 117.00M 116.07M 116.56M
Diluted average shares 119.14M 118.12M 117.00M 116.07M 116.56M
EBITDA 1.95B 2.36B 1.33B 520.01M 628.14M
Net income from continuing op. 910.36M 1.29B 640.64M -553.56M 122.98M
Minority interests -64.29M -72.11M -55.67M -39.65M -35.21M
Preferred stock dividends

Balance sheet

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 7.73B 5.55B 4.26B 3.69B 4.07B
Current assets
Cash 52.66M 505.18M 48.14M 57.92M 40.02M
Cash equivalents
Cash and cash equivalents 52.66M 505.18M 48.14M 57.92M 40.02M
Other short term investments
Accounts receivable 437.85M 405.81M 212.61M 119.92M 162.77M
Other receivables 35.10M 48.01M 28.81M 17.21M 26.64M
Inventory 41.81M 15.18M 12.19M 10.58M 10.74M
Prepaid assets 28.81M 15.80M 13.21M
Restricted cash 53.64M 42.15M 38.79M 33.47M 25.10M
Assets held for sale
Hedging assets 2.11M 3.93M 1.97M 6.73M
Other current assets 92.70M 51.57M 28.81M
Non current assets
Properties 1.32B 1.06B 900.98M 841.70M 643.90M
Land and improvements
Machinery furniture equipment 26.23M 21.48M 19.15M 18.71M 17.27M
Construction in progress
Leases 14.15M 11.37M 10.98M 10.85M 9.75M
Accumulated depreciation -5.23B -4.51B -4.05B -3.70B -2.66B
Goodwill
Investment properties
Financial assets 558,000 2.57M
Intangible assets
Investments and advances
Other non current assets 54.13M 64.48M 34.16M 55.31M 91.59M
Total liabilities 3.60B 2.24B 2.13B 2.17B 2.10B
Current liabilities
Accounts payable 68.19M 58.85M 26.26M 13.98M 25.23M
Accrued expenses 288.84M 202.42M 209.55M 93.84M 164.05M
Short term debt 62.01M 46.98M 32.18M 24.28M 18.22M
Deferred revenue 19.95M 52.36M 18.07M 4.19M 14.84M
Tax payable
Pensions
Other current liabilities 40.62M 52.86M 45.54M 82.62M 53.73M
Non current liabilities
Long term debt 2.21B 1.16B 1.53B 1.81B 1.58B
Provision for risks and charges
Deferred liabilities 581.44M 428.35M 77.94M 37.33M
Derivative product liabilities 1.98M
Other non current liabilities 38.48M 19.96M 22.72M 30.40M 43.13M
Shareholders equity
Common stock 1.19M 1.19M 1.18M 1.17M 1.17M
Retained earnings 1.78B 1.01B -171.32M -741.71M -148.50M
Other shareholders equity
Total shareholders equity 4.13B 3.32B 2.13B 1.51B 1.97B
Additional paid in capital 2.13B 2.10B 2.08B 2.03B 1.98B
Treasury stock 45,000 34,000 243,000 3,000 26,000
Minority interest 216.83M 206.29M 220.18M 226.50M 135.80M

Cash flow statement

202320222021202020192018201720162015201420132012201120102009
Operating Activities
Net Income910.36M1.29B640.64M-553.56M122.98M299.76M138.01M-97.06M-679.52M110.75M45.09M-33.26M-10.31M6.38M-14.43M
Depreciation716.69M466.35M344.91M361.83M350.54M265.14M177.50M122.05M178.85M134.74M98.40M80.45M31.75M15.60M10.74M
Deferred Taxes172.10M344.48M74.71M-45.60M35.53M-7.24M-150.33M64.24M9.29M-1.43M-5.48M4.93M-7.60M
Stock-Based Compensation13.66M15.12M9.04M13.63M18.51M17.20M16.65M12.36M9.45M5.52M3.90M140,0002.41M898,000
Other Non-Cash Items3.73M3.22M6.06M4.78M4.31M2.89M1.76M2.33M1.59M504,000348,000256,000209,000155,000793,434
Accounts Receivable59.89M-205.43M-98.46M53.00M-43.26M-4.93M-82.55M-14.26M3.63M-13.32M-2.16M-16.34M-1.52M-386,000408,710
Accounts Payable2.81M63.46M76.89M-43.84M-19.00M68.65M33.56M6.61M1.38M607,000-3.64M19.74M13.50M2.49M
Other Assets & Liabilities-35.19M23.65M4.06M1.79M11.84M-5.69M-17.99M3.93M-243,000814,000110,000-341,000-180,000126,000-496,999
Operating Cash Flow1.84B2.00B1.06B-207.98M481.44M635.78M266.94M35.97M-635.20M303.86M151.34M49.22M30.38M30.19M-10.58M
Investing Activities
Capital Expenditures-187.66M-230.89M-238.61M-72.81M-50.77M-652.86M-5.69M-74.85M-64.50M79,000-3.98M-161.10M-160.66M-54.52M
Net Intangibles
Net Acquisitions-24.03M
Purchase of Investments-61,000-496,000-4.30M-3.74M-15.50M
Sale of Investments230,0001.60M5.31M17.07M20.61M
Investing Cash Flow-1.85B-184.38M-234.39M-68.02M-28.85M-644.52M-4.71M-69.67M7.56M-451,000-3.81M1.11M-160.09M-147.33M-49.42M
Financing Activities
Long-Term Debt Issuance4.25B430.00M395.00M266.00M250.00M1.68B304.63M525.00M320.00M180.00M160.00M191.00M25.00M
Long-Term Debt Payments-3.20B-794.30M-684.00M-35.00M-35.00M-975.78M-120.00M-476.98M-180.00M-130.00M-123.00M-103.00M
Other Financing Charges-72.29M-81.30M-24.97M93.34M46.78M-44.92M196.86M-5.53M-11.80M-748,000-7.41M-11.58M-1.71M-172,000
Financing Cash Flow902.33M-480.85M-277.55M370.34M329.78M887.42M405.58M467.61M224.93M321.13M191.66M171.84M86.61M34.91M-195,768
Other Cash Details
End Cash Position106.30M547.33M86.92M91.38M65.13M83.98M102.48M214.14M16.73M8.41M6.29M2.10M10.28M21.06M104.23M
Income Tax Paid4.60M63.50M
Interest Paid111.74M72.56M74.84M76.88M780,000
Free Cash Flow318.02M894.76M319.88M-302.87M-373.86M-915.06M-521.14M-319.83M-288.68M-318.52M-187.70M-183.79M-99.23M-133.39M-52.76M

Top Institutional Holders

Holder Date Reported Shares Value % Held
iShares Core S&P Midcap ETF Nov 30, 2024 3,728,043 217.61M 2.99%
Vanguard Total Stock Market Index Fund Sep 30, 2024 3,560,336 207.82M 2.85%
Vanguard Small-Cap Index Fund Sep 30, 2024 2,811,943 164.13M 2.25%
Price (T.Rowe) Small-Cap Value Fund Sep 30, 2024 2,189,787 127.82M 1.76%
Vanguard Extended Market Index Fund Sep 30, 2024 1,745,197 101.87M 1.40%
Victory Portfolios-Sycamore Small Company Opportunity Fund Sep 30, 2024 1,590,000 92.81M 1.27%
Vanguard Small-Cap Growth Index Fund Sep 30, 2024 1,550,680 90.51M 1.24%
SPDR (R) Ser Tr-SPDR (R) S&P (R) Oil & Gas Explor & Prod ETF Nov 30, 2024 1,315,043 76.76M 1.05%
Price (T.Rowe) U.S. Small-Cap Value Equity Trust Sep 30, 2024 1,178,792 68.81M 0.94%
Vanguard Explorer Fund, Inc. Oct 31, 2024 1,053,324 61.48M 0.84%
Matador (MTDR) Upgraded to Buy: Here's What You Should Know Article
Matador (MTDR) Upgraded to Buy: Here's What You Should Know
Matador (MTDR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research Positive
Feb 4, 2025
Matador Resources Company Announces Appointment of New Director Article
Matador Resources Company Announces Appointment of New Director
DALLAS--(BUSINESS WIRE)--Matador Resources Company (NYSE: MTDR) (“Matador”) today announced the appointment of Paul W. Harvey to its Board of Directors (the “Board”). Mr. Harvey is the former Chief Investment Officer and Senior Portfolio Manager and current Private Wealth Advisor with Vaquero Private Wealth in Dallas, Texas. Mr. Harvey has more than four decades of investment experience as both a portfolio manager and private wealth advisor with significant experience as an investor in oil and.
Business Wire Neutral
Jan 28, 2025
Undercovered Dozen: Virgin Galactic, Gold Fields, Matador Resources, EHang + Article
Undercovered Dozen: Virgin Galactic, Gold Fields, Matador Resources, EHang +
The 'Undercovered' Dozen highlights 12 lesser-covered stocks, offering investment ideas and encouraging discussions on their potential and market outlook. Beyond Inc. is rated a Strong Buy by Oskar Goyvaerts due to its turnaround plan, new CEO, and cost cuts aiming for breakeven FCF by Q3 2025. BioCGT Investor discusses the potential of Editas Medicine and Intellia Therapeutics despite market pessimism, with strategic pipeline reprioritization and significant upside targets possible.
Seeking Alpha Neutral
Jan 25, 2025
Scroll to Top

Markets

Crypto

how to invest

Who we are